BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 26773193)

  • 1. Oocyte vitrification for elective fertility preservation: lessons for patient counseling.
    Stoop D
    Fertil Steril; 2016 Mar; 105(3):603-604. PubMed ID: 26773193
    [No Abstract]   [Full Text] [Related]  

  • 2. Oocyte vitrification as an efficient option for elective fertility preservation.
    Cobo A; García-Velasco JA; Coello A; Domingo J; Pellicer A; Remohí J
    Fertil Steril; 2016 Mar; 105(3):755-764.e8. PubMed ID: 26688429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful elective and medically indicated oocyte vitrification and warming for autologous in vitro fertilization, with predicted birth probabilities for fertility preservation according to number of cryopreserved oocytes and age at retrieval.
    Doyle JO; Richter KS; Lim J; Stillman RJ; Graham JR; Tucker MJ
    Fertil Steril; 2016 Feb; 105(2):459-66.e2. PubMed ID: 26604065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oocyte vitrification for fertility preservation in women with endometriosis: an observational study.
    Cobo A; Giles J; Paolelli S; Pellicer A; Remohí J; García-Velasco JA
    Fertil Steril; 2020 Apr; 113(4):836-844. PubMed ID: 32145929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro maturation of human immature oocytes for fertility preservation.
    Chian RC; Uzelac PS; Nargund G
    Fertil Steril; 2013 Apr; 99(5):1173-81. PubMed ID: 23433515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oocyte vitrification versus ovarian cortex transplantation in fertility preservation for adult women undergoing gonadotoxic treatments: a prospective cohort study.
    Diaz-Garcia C; Domingo J; Garcia-Velasco JA; Herraiz S; Mirabet V; Iniesta I; Cobo A; Remohí J; Pellicer A
    Fertil Steril; 2018 Mar; 109(3):478-485.e2. PubMed ID: 29428307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Five years' experience using oocyte vitrification to preserve fertility for medical and nonmedical indications.
    Garcia-Velasco JA; Domingo J; Cobo A; Martínez M; Carmona L; Pellicer A
    Fertil Steril; 2013 Jun; 99(7):1994-9. PubMed ID: 23465707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oocyte vitrification for elective fertility preservation: the past, present, and future.
    Gunnala V; Schattman G
    Curr Opin Obstet Gynecol; 2017 Feb; 29(1):59-63. PubMed ID: 27922944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Practical clinical aspects of oocyte vitrification for fertility preservation].
    Courbiere B; Decanter C
    Gynecol Obstet Fertil; 2014 Sep; 42(9):653-6. PubMed ID: 25164159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fertility preservation utilizing controlled ovarian hyperstimulation and oocyte cryopreservation in a premenarcheal female with myelodysplastic syndrome.
    Stoop D; De Vos M; Tournaye H; Devroey P
    Fertil Steril; 2012 Nov; 98(5):1121-2. PubMed ID: 22883568
    [No Abstract]   [Full Text] [Related]  

  • 11. Immature oocyte retrieval and in vitro oocyte maturation at different phases of the menstrual cycle in women with cancer who require urgent gonadotoxic treatment.
    Creux H; Monnier P; Son WY; Tulandi T; Buckett W
    Fertil Steril; 2017 Jan; 107(1):198-204. PubMed ID: 27810160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective study of women and girls undergoing fertility preservation due to oncologic and non-oncologic indications in Sweden-Trends in patients' choices and benefit of the chosen methods after long-term follow up.
    Rodriguez-Wallberg KA; Marklund A; Lundberg F; Wikander I; Milenkovic M; Anastacio A; Sergouniotis F; Wånggren K; Ekengren J; Lind T; Borgström B
    Acta Obstet Gynecol Scand; 2019 May; 98(5):604-615. PubMed ID: 30723910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Planned Oocyte Cryopreservation: A Review of Current Evidence on Outcomes, Safety and Risks.
    Song BB; Quinn MM
    Obstet Gynecol Clin North Am; 2023 Dec; 50(4):707-719. PubMed ID: 37914489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accumulation of oocytes: a new strategy for managing low-responder patients.
    Cobo A; Garrido N; Crespo J; José R; Pellicer A
    Reprod Biomed Online; 2012 Apr; 24(4):424-32. PubMed ID: 22386762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A healthy dose of reality for the egg-freezing party.
    Schattman GL
    Fertil Steril; 2016 Feb; 105(2):307. PubMed ID: 26688557
    [No Abstract]   [Full Text] [Related]  

  • 16. Fertility preservation using controlled ovarian hyperstimulation and oocyte cryopreservation in a premenarcheal female with myelodysplastic syndrome.
    Reichman DE; Davis OK; Zaninovic N; Rosenwaks Z; Goldschlag DE
    Fertil Steril; 2012 Nov; 98(5):1225-8. PubMed ID: 22884018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Planned oocyte cryopreservation for women seeking to preserve future reproductive potential: an Ethics Committee opinion.
    ;
    Fertil Steril; 2018 Nov; 110(6):1022-1028. PubMed ID: 30396539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oocyte cryopreservation review: outcomes of medical oocyte cryopreservation and planned oocyte cryopreservation.
    Walker Z; Lanes A; Ginsburg E
    Reprod Biol Endocrinol; 2022 Jan; 20(1):10. PubMed ID: 34996479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Double-in vitro maturation increases the number of vitrified oocytes available for fertility preservation when ovarian stimulation is unfeasible.
    Sermondade N; Grynberg M; Comtet M; Valdelievre C; Sifer C; Sonigo C
    Sci Rep; 2020 Oct; 10(1):18555. PubMed ID: 33122722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ovarian response to controlled ovarian hyperstimulation in cancer patients is diminished even before oncological treatment.
    Domingo J; Guillén V; Ayllón Y; Martínez M; Muñoz E; Pellicer A; Garcia-Velasco JA
    Fertil Steril; 2012 Apr; 97(4):930-4. PubMed ID: 22283969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.